DLX105

DRUG2 trials

Sponsors

Delenex Therapeutics AG

Conditions

Fistulizing Crohn's DiseaseMild-to-moderate Psoriasis Vulgaris

Phase 1

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris

CompletedNCT01595997

Delenex Therapeutics AGMild-to-moderate Psoriasis Vulgaris

Start: 2012-02-29End: 2012-10-31Target: 20Updated: 2013-01-08

Phase 2

Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease

CompletedNCT01624376

Delenex Therapeutics AGFistulizing Crohn's Disease

Start: 2012-06-30End: 2013-08-31Updated: 2014-02-04